Navigation Links
DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs
Date:11/5/2012

CUPERTINO, Calif., Nov. 5, 2012 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months ended September 30, 2012. Total revenues were $3.8 million for the three months ended September 30, 2012 as compared to $8.1 million for the three months ended September 30, 2011.  Net loss for the three months ended September 30, 2012 was $4.8 million, compared to a net loss of $5.0 million for the same period in 2011.

(Logo:  http://photos.prnewswire.com/prnh/20020717/DRRXLOGO)

At September 30, 2012, we had cash and investments of $21.0 million, compared to cash and investments of $23.7 million at June 30, 2012 and $30.8 million at December 31, 2011.  We have no debt obligations, other than normal liabilities associated with running our business."Following our pre-NDA communications with the FDA this summer, we are preparing to submit a new drug application for POSIDUR in the first quarter of 2013," stated James E. Brown, D.V.M., President and CEO of DURECT.  "Pfizer has initiated a confirmatory bioavailability study to assess the pharmacokinetic profile of modified REMOXY formulation compositions, with a data read out expected early in 2013.  We also are pleased that Zogenix has been actively enrolling in the Phase I clinical trial for Relday."

Update of Programs:

  • REMOXY® (oxycodone) Extended-Release Capsules CII.  Pfizer has efforts underway to resolve the issues raised in the REMOXY Complete Response Letter and stated in their quarterly earnings call on November 1, 2012 that they have initiated a confirmatory bioavailability study to assess the pharmacokinetic profile of modified REMOXY formulation compositions, with data expected in early 2013.  Pfizer expects that the results of this study wi
    '/>"/>

  • SOURCE DURECT Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call
    2. DURECT to Participate in Upcoming Healthcare Conferences
    3. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
    4. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
    5. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
    6. Psychemedics Corporation Announces 3rd Quarter Earnings
    7. RayBiotech, Inc. and Abeome Corporation Announce an Agreement Related to Novel Research Products for Ovarian Cancer
    8. CombiMatrix Corporation Selects Cartagenia BENCHlab CNV Platform to Bolster Expanded Lab Operations
    9. United Therapeutics Corporation Reports Third Quarter 2012 Financial Results
    10. Fish & Richardson Prevails in Patent Infringement Trial for Volcano Corporation
    11. Luminex Corporation Reports Third Quarter 2012 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/20/2015)... April 20, 2015 Pharmaceutical Research and Manufacturers ... billion last year in the research and development (R&D) ... the majority of all biopharmaceutical R&D spending – both ... States . The new R&D numbers, the result ... highlighted in the newly released PhRMA 2015 ...
    (Date:4/20/2015)...  Purdue Pharma, a leading specialty pharmaceutical company, ... joined the company as Senior Vice President of ... for all of Purdue,s efforts to acquire or ... benefit from our patient-focused commercial capabilities. ... President & CEO Mark Timney . "Alan ...
    (Date:4/20/2015)... LINCOLNSHIRE, Ill. , April 20, 2015  U.S. pharmacy ... are expected to drift into the low double-digits by 2016, ... global talent, retirement and health solutions business of Aon ... plan design changes are projected to be 9.5 percent in ... 2016. Aon Hewitt predicts a similar rate of ...
    Breaking Medicine Technology:PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 2PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 3Purdue Pharma Names J. Alan Butcher Senior Vice President of Licensing & Business Development 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4
    ... Corp. (NASDAQ: KOOL ), a leading supplier of ... cells, said today that Mahendra Rao, M.D., Ph.D. has resigned ... Rao has been appointed to a position with the National ... a director of the Company, pursuant to NIH and federal ...
    ... 1, 2011 Merrimack Pharmaceuticals, Inc. announced today ... has granted MM-398 orphan drug status for the ... stable nanotherapeutic encapsulation of the marketed chemotherapy drug ... development and commercialization in Taiwan under the designation ...
    Cached Medicine Technology:ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao 2ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao 3FDA Grants Orphan Drug Status to Merrimack Pharmaceuticals' MM-398, a Nanotherapeutic Encapsulation of Irinotecan, for the Treatment of Pancreatic Cancer 2
    (Date:4/21/2015)... 2015 CALNOC, the nation’s first nursing ... RN, FAAN, will keynote their upcoming conference – Navigating ... CA on October 26, 2015. , Dr. Burnes ... of Nurse Executives (AONE) and the first African American ... American Academy of Nursing and the National Black Nurses ...
    (Date:4/21/2015)... Renewable energy, sustainable living, the greening of ... Day topics USM Studios ’ programming covers in ... affect of climate change on the planet, the award-winning ... on the environmental concerns affecting the nation and world ... lifestyles, clean air options, and much more when the ...
    (Date:4/21/2015)... TX (PRWEB) April 21, 2015 ... from a prestigious Illinois university for a second ... units (NICUs) more conducive to newborn infants’ cognitive ... top three NICU problems we have identified through ... care professionals,” said George Hutchinson, Invictus Medical’s Chief ...
    (Date:4/20/2015)... (PRWEB) April 20, 2015 Heritage Woods ... host an Open House and Dine-and-Dash Spaghetti Dinner from ... The community, which is located in Centralia, Illinois, houses ... homes for low-income adults 55 and older. , Guests ... staff about supportive living options for seniors. After the ...
    (Date:4/20/2015)... 21, 2015 Reality show stars, food, ... at the twentieth annual Michigan International Women’s Show, April ... , “There is lots to see and do from ... for fashion and gifts,” said Beth Anderson, executive show ... and encouraging with appearances from Randy Fenoli of ‘Say ...
    Breaking Medicine News(10 mins):Health News:Nationally Recognized Nurse Leader Linda Burnes Bolton to Present Keynote Address at CALNOC Conference 2Health News:USM Studios’ Programming Focuses on the Environment 2Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2Health News:Heritage Woods of Centralia Senior Living Community to Host Open House and Spaghetti Dinner 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 3
    ... Behen HealthDay Reporter , FRIDAY, Jan. 20 (HealthDay ... good job of informing American women with early stage breast ... surgery, a new study suggests. In the study, researchers ... on their knowledge of the disease. Respondents typically answered only ...
    ... Quitting smoking is never easy. However, when you,re poor ... hard, according to a new study by a tobacco ... (CCNY). Christine Sheffer, associate medical professor at CCNY,s ... different socioeconomic backgrounds after they had completed a statewide ...
    ... The Mount Sinai Medical Center in New York have ... known as phthalates and obesity in young children ... Phthalates are man-made, endocrine-disrupting chemicals that can ... in plastic flooring and wall coverings, food processing materials, ...
    ... ON When cancers become aggressive and spread they ... how to stop this development. A new imaging platform ... and John Lewis is providing insight into just that ... Certain proteins, such as E-cadherin, are important for ...
    ... per cent of patients hospitalized after a stroke develop delirium, ... Researchers found patients who experience delirium after stroke are five ... be discharged to a long-term care facility, nursing home or ... and prevention of delirium are important for a quick recovery, ...
    ... are the Robinson Crusoes of the intracellular world -- ... where their fellow chromosomes reside. Such castaways, each confined ... cells, but scientists haven,t known what role, if any, ... paper published online on Jan. 18 by the journal ...
    Cached Medicine News:Health News:Many Breast Cancer Patients Uninformed About Options: Study 2Health News:Many Breast Cancer Patients Uninformed About Options: Study 3Health News:Poorest smokers face toughest odds for kicking the habit 2Health News:Exposure to chemical found in personal care products may contribute to childhood obesity 2Health News:Lawson researchers engineer a switch to tame aggressive cancers 2Health News:Study finds delirium after stroke linked to poorer outcomes for patients 2Health News:'Pulverized' chromosomes linked to cancer? 2Health News:'Pulverized' chromosomes linked to cancer? 3
    ... design allows "Four gels in one tank" electrophoresis. ... run 200 samples or more in one compact ... gels. To ensure even migration, the electrode height ... being run. Ideal for high throughput procedures, an ...
    ... tanks come with turn and cast gel ... pouring as simple as possible. , ... your application. Avaialble in a variety of ... gel size right up to the 20 ...
    ... UniPhor units can be used for: ... and non denaturing SDS-PAGE gels IEF ... Z64,075 1) Preparative Protein and Peptide ... gels IEF in Agarose Ampholyte Gels ...
    ... Horizontal Gel System provides a compact format ... DNA fragments, PCR products and synthetic oligonucleotides, ... The Mini Horizontal Unit has gel bed ... The gel bed is UV transparent. Adjustable ...
    Medicine Products: